Chapter/Section Purchase

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Parkinson?s Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson?s Disease Therapeutics Segment by Type
1.2.2 Parkinson?s Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Parkinson?s Disease Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Parkinson?s Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinson?s Disease Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Parkinson?s Disease Therapeutics Market Competitive Landscape
3.1 Global Parkinson?s Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson?s Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson?s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson?s Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson?s Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson?s Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson?s Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson?s Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Parkinson?s Disease Therapeutics Industry Chain Analysis
4.1 Parkinson?s Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Parkinson?s Disease Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Parkinson?s Disease Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson?s Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson?s Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson?s Disease Therapeutics Price by Type (2019-2024)
7 Parkinson?s Disease Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson?s Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson?s Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson?s Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 Parkinson?s Disease Therapeutics Market Segmentation by Region
8.1 Global Parkinson?s Disease Therapeutics Sales by Region
8.1.1 Global Parkinson?s Disease Therapeutics Sales by Region
8.1.2 Global Parkinson?s Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson?s Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson?s Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson?s Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson?s Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson?s Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Abbvie
9.1.1 Abbvie Parkinson?s Disease Therapeutics Basic Information
9.1.2 Abbvie Parkinson?s Disease Therapeutics Product Overview
9.1.3 Abbvie Parkinson?s Disease Therapeutics Product Market Performance
9.1.4 Abbvie Business Overview
9.1.5 Abbvie Parkinson?s Disease Therapeutics SWOT Analysis
9.1.6 Abbvie Recent Developments
9.2 Biogen
9.2.1 Biogen Parkinson?s Disease Therapeutics Basic Information
9.2.2 Biogen Parkinson?s Disease Therapeutics Product Overview
9.2.3 Biogen Parkinson?s Disease Therapeutics Product Market Performance
9.2.4 Biogen Business Overview
9.2.5 Biogen Parkinson?s Disease Therapeutics SWOT Analysis
9.2.6 Biogen Recent Developments
9.3 Boehringer Ingelheim GmbH
9.3.1 Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Basic Information
9.3.2 Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Product Overview
9.3.3 Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics Product Market Performance
9.3.4 Boehringer Ingelheim GmbH Parkinson?s Disease Therapeutics SWOT Analysis
9.3.5 Boehringer Ingelheim GmbH Business Overview
9.3.6 Boehringer Ingelheim GmbH Recent Developments
9.4 F. Hoffman-La Roche
9.4.1 F. Hoffman-La Roche Parkinson?s Disease Therapeutics Basic Information
9.4.2 F. Hoffman-La Roche Parkinson?s Disease Therapeutics Product Overview
9.4.3 F. Hoffman-La Roche Parkinson?s Disease Therapeutics Product Market Performance
9.4.4 F. Hoffman-La Roche Business Overview
9.4.5 F. Hoffman-La Roche Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Parkinson?s Disease Therapeutics Basic Information
9.5.2 GlaxoSmithKline Parkinson?s Disease Therapeutics Product Overview
9.5.3 GlaxoSmithKline Parkinson?s Disease Therapeutics Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 H. Lundbeck A/S
9.6.1 H. Lundbeck A/S Parkinson?s Disease Therapeutics Basic Information
9.6.2 H. Lundbeck A/S Parkinson?s Disease Therapeutics Product Overview
9.6.3 H. Lundbeck A/S Parkinson?s Disease Therapeutics Product Market Performance
9.6.4 H. Lundbeck A/S Business Overview
9.6.5 H. Lundbeck A/S Recent Developments
9.7 Impax Labs
9.7.1 Impax Labs Parkinson?s Disease Therapeutics Basic Information
9.7.2 Impax Labs Parkinson?s Disease Therapeutics Product Overview
9.7.3 Impax Labs Parkinson?s Disease Therapeutics Product Market Performance
9.7.4 Impax Labs Business Overview
9.7.5 Impax Labs Recent Developments
9.8 Newron Pharmaceuticals SpA
9.8.1 Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Basic Information
9.8.2 Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Product Overview
9.8.3 Newron Pharmaceuticals SpA Parkinson?s Disease Therapeutics Product Market Performance
9.8.4 Newron Pharmaceuticals SpA Business Overview
9.8.5 Newron Pharmaceuticals SpA Recent Developments
9.9 Novartis AG
9.9.1 Novartis AG Parkinson?s Disease Therapeutics Basic Information
9.9.2 Novartis AG Parkinson?s Disease Therapeutics Product Overview
9.9.3 Novartis AG Parkinson?s Disease Therapeutics Product Market Performance
9.9.4 Novartis AG Business Overview
9.9.5 Novartis AG Recent Developments
9.10 Orion Corporation
9.10.1 Orion Corporation Parkinson?s Disease Therapeutics Basic Information
9.10.2 Orion Corporation Parkinson?s Disease Therapeutics Product Overview
9.10.3 Orion Corporation Parkinson?s Disease Therapeutics Product Market Performance
9.10.4 Orion Corporation Business Overview
9.10.5 Orion Corporation Recent Developments
9.11 Teva Pharmaceutical Industries Ltd.
9.11.1 Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Basic Information
9.11.2 Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Product Overview
9.11.3 Teva Pharmaceutical Industries Ltd. Parkinson?s Disease Therapeutics Product Market Performance
9.11.4 Teva Pharmaceutical Industries Ltd. Business Overview
9.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
9.12 UCB S.A.
9.12.1 UCB S.A. Parkinson?s Disease Therapeutics Basic Information
9.12.2 UCB S.A. Parkinson?s Disease Therapeutics Product Overview
9.12.3 UCB S.A. Parkinson?s Disease Therapeutics Product Market Performance
9.12.4 UCB S.A. Business Overview
9.12.5 UCB S.A. Recent Developments
9.13 Livzon Pharmaceutical
9.13.1 Livzon Pharmaceutical Parkinson?s Disease Therapeutics Basic Information
9.13.2 Livzon Pharmaceutical Parkinson?s Disease Therapeutics Product Overview
9.13.3 Livzon Pharmaceutical Parkinson?s Disease Therapeutics Product Market Performance
9.13.4 Livzon Pharmaceutical Business Overview
9.13.5 Livzon Pharmaceutical Recent Developments
9.14 Haisco Pharmaceutical
9.14.1 Haisco Pharmaceutical Parkinson?s Disease Therapeutics Basic Information
9.14.2 Haisco Pharmaceutical Parkinson?s Disease Therapeutics Product Overview
9.14.3 Haisco Pharmaceutical Parkinson?s Disease Therapeutics Product Market Performance
9.14.4 Haisco Pharmaceutical Business Overview
9.14.5 Haisco Pharmaceutical Recent Developments
9.15 Jingxin Pharmaceutical
9.15.1 Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Basic Information
9.15.2 Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Product Overview
9.15.3 Jingxin Pharmaceutical Parkinson?s Disease Therapeutics Product Market Performance
9.15.4 Jingxin Pharmaceutical Business Overview
9.15.5 Jingxin Pharmaceutical Recent Developments
9.16 Dongcheng Biochemicals
9.16.1 Dongcheng Biochemicals Parkinson?s Disease Therapeutics Basic Information
9.16.2 Dongcheng Biochemicals Parkinson?s Disease Therapeutics Product Overview
9.16.3 Dongcheng Biochemicals Parkinson?s Disease Therapeutics Product Market Performance
9.16.4 Dongcheng Biochemicals Business Overview
9.16.5 Dongcheng Biochemicals Recent Developments
10 Parkinson?s Disease Therapeutics Market Forecast by Region
10.1 Global Parkinson?s Disease Therapeutics Market Size Forecast
10.2 Global Parkinson?s Disease Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinson?s Disease Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Parkinson?s Disease Therapeutics Market Size Forecast by Region
10.2.4 South America Parkinson?s Disease Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinson?s Disease Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Parkinson?s Disease Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinson?s Disease Therapeutics by Type (2025-2030)
11.1.2 Global Parkinson?s Disease Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinson?s Disease Therapeutics by Type (2025-2030)
11.2 Global Parkinson?s Disease Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Parkinson?s Disease Therapeutics Sales (Kilotons) Forecast by Application
11.2.2 Global Parkinson?s Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings